Skip to main content

Table 2 Comparison of treatment groups after 3 doses of anti-VEGF (3rd month) in terms of evaluation parameters

From: Comparison of the efficacy of intravitreal Anti-VEGF versus intravitreal dexamethasone implant in treatment resistant diabetic Macular Edema

 

AFL + AFL

RAN + RAN

AFL + DEX

RAN + DEX

P Value

Visual Acuity (LogMAR)

0.59 ± 0.26

0.64 ± 0.32

0.8 ± 0.4

0.85 ± 0.43

0.260

Central Macular Thickness (µm)

403.6 ± 70.4

411.5 ± 84

413.6 ± 88.1

418.1 ± 88

0.964

Intraocular Pressure (mmHg)

15.3 ± 2.7

15.4 ± 2.9

14.7 ± 2.9

16.2 ± 3.2

0.392

Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us